SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 27th, 2017 • Cantabio Pharmaceuticals Inc. • Pharmaceutical preparations • New York
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of November 20, 2017, is between CANTABIO PHARMACEUTICALS INC., a company incorporated under the laws of the State of Delaware, with headquarters located at 1250 Oakmead Pkwy, Sunnyvale, California, 94085 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively the “Buyers”).
SECURITY AGREEMENT (in favor of YA II PN, Ltd.)Security Agreement • November 27th, 2017 • Cantabio Pharmaceuticals Inc. • Pharmaceutical preparations • New York
THIS SECURITY AGREEMENT (the “Agreement”) is entered into as of November 20, 2017 by and among (i) Cantabio Pharmaceuticals Inc., a Delaware corporation (the “Issuer”), and (ii) any subsidiary and affiliate of the Issuer listed on Schedule 1 attached hereto either now or joined in the future (the “Subsidiaries”; and jointly, severally, and collectively with the Issuer, the “Grantors”) in favor of YA II PN, Ltd., a Cayman Islands company (the “Secured Party”).
AMENDMENT AGREEMENTAmendment Agreement • November 27th, 2017 • Cantabio Pharmaceuticals Inc. • Pharmaceutical preparations • New York
This Amendment Agreement (the “Agreement”), dated as of November 20, 2017, is entered into by and between Cantabio Pharmaceuticals Inc., a Delaware corporation (the “Company”), and YA II PN, Ltd. (the “Note Holder”) and is the basis for the amendment of three convertible notes (as discussed below) the Company issued to the Note Holder.
